Teladoc Health Inc buy Royal Bank of Canada
Start price
26.04.24
/
50%
€12.29
Target price
26.04.25
€16.82
Performance (%)
-32.94%
Price
04.10.24
€8.24
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Teladoc Health Inc is performing very badly with a performance of -32.94%. This prediction currently runs until 26.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Teladoc Health Inc | 8.690% | 8.690% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Teladoc Health Inc diskutieren
Teladoc Health, Inc. (NYSE: TDOC) had its price target lowered by analysts at Royal Bank of Canada from $25.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for TDOC provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Teladoc Health Inc
Teladoc Health Inc
Start price
Target price
Perf. (%)
€14.32
21.02.24
21.02.24
€23.12
21.02.25
21.02.25
-42.44%
04.10.24
04.10.24
Teladoc Health Inc
Start price
Target price
Perf. (%)
€16.46
25.10.23
25.10.23
€28.38
25.10.24
25.10.24
-49.93%
04.10.24
04.10.24